Condensed Consolidated Statements Of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Cash flows from operating activities:
Net earnings	$ 87.1	$ 66.4
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	498.5	415.5
Share-based Compensation	21.4	23.1
Deferred income tax expense	16.0	35.6
Loss from equity method investments	23.1	33.2
Other non-cash items	38.0	98.8
Litigation settlements and other contingencies, net	16.4	8.9
Changes in operating assets and liabilities:
Accounts receivable	370.2	286.7
Inventories	(157.6)	(105.6)
Trade accounts payable	(92.8)	(242.7)
Income taxes	(155.7)	(175.0)
Other operating assets and liabilities, net	(42.8)	8.0
Net cash provided by operating activities	621.8	452.9
Cash flows from investing activities:
Cash paid for acquisitions, net	(63.3)	(71.6)
Capital expenditures	(30.7)	(58.4)
Proceeds from the sale of assets	0.0	31.1
Purchase of marketable securities	(7.5)	(2.3)
Proceeds from the sale of marketable securities	15.0	2.3
Payments for product rights and other, net	(342.4)	(77.9)
Net cash used in investing activities	(428.9)	(176.8)
Cash flows from financing activities:
Payments of long-term debt	(498.0)	(550.0)
Purchase of ordinary shares	(432.0)	0.0
Change in short-term borrowings, net	309.1	(17.6)
Taxes paid related to net share settlement of equity awards	(8.9)	(6.1)
Contingent consideration payments	(0.2)	(3.8)
Payments of financing fees	(0.4)	(3.7)
Proceeds from issuance of long-term debt	498.4	0.0
Proceeds from exercise of stock options	10.8	5.0
Other items, net	(0.2)	0.5
Net cash used in financing activities	(121.4)	(575.7)
Effect on cash of changes in exchange rates	3.7	12.2
Net increase (decrease) in cash, cash equivalents and restricted cash	75.2	(287.4)
Cash, cash equivalents and restricted cash — end of period	367.4	723.8
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 445.1	$ 859.6